Biosimilar Newsletter Archive
-
06.29.23 -- Improving Digital Integration Between Biomanufacturers & Partners
6/29/2023
06/29/23 Biosimilar Development Newsletter
-
06.22.23 -- 5 Characteristics Of The Automated Microbiology Lab Of The Future
6/22/2023
06/22/23 Biosimilar Development Newsletter
-
06.15.23 -- Pfizer, Samsung Biologics Announce Biosimilar Manufacturing Collaboration
6/15/2023
06/15/23 Biosimilar Development Newsletter
-
06.14.23 -- A New Vial Design Capable Of Curbing Delamination And Glass Particulate Generation
6/14/2023
06/14/23 Biosimilar Development Newsletter
-
06.09.23 -- Strategies To Streamline Combination Product Development For Biosimilars
6/9/2023
06/09/23 Biosimilar Development Newsletter
-
06.08.23 -- Mark Cuban, Coherus Team Up For Broader Humira Access
6/8/2023
06/08/23 Biosimilar Development Newsletter
-
06.07.23 -- Antibody Variants, Mechanistic Modeling, And High-Throughput Process Development
6/7/2023
06/07/23 Biosimilar Development Newsletter
-
06.05.23 -- Unlock The Potential Of Your Biopharmaceutical Development
6/5/2023
06/05/23 Biosimilar Development Newsletter
-
06.01.23 -- Risk-Based Strategies For Revalidating Bio/Pharma Equipment & Systems
6/1/2023
06/01/23 Biosimilar Development Newsletter
-
05.25.23 -- The Global Market For Biosimilars Through 2032
5/25/2023
05/25/23 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more